Skip to main content
Fig. 4 | BMC Infectious Diseases

Fig. 4

From: Use of ceragenins as a potential treatment for urinary tract infections

Fig. 4

Antibiofilm activities of LL-37 (black columns), doxycycline (DOX) (white columns), CSA-13 (dark grey columns), CSA-131 (light grey columns) against E. coli (*) (Panels a, c, e, g) and antibiofilm activities of combination of LL-37 with doxycycline (white columns), LL-37 with CSA-13 (dark grey columns) and LL-37 with CSA-131 (light grey strips) against E. coli (*) clinical strains after 48 h (Panels b, d, f, h)

Back to article page